Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 10,600 shares, a decline of 19.1% from the May 15th total of 13,100 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,900 shares, the short-interest ratio is currently 2.2 days.

Procaps Group Price Performance

Procaps Group stock traded up $0.03 during midday trading on Friday, reaching $2.60. 1,430 shares of the stock traded hands, compared to its average volume of 6,974. The stock has a market cap of $293.33 million, a P/E ratio of 5.00 and a beta of 0.17. The stock’s fifty day moving average is $2.72 and its 200-day moving average is $3.19. The company has a quick ratio of 0.99, a current ratio of 1.47 and a debt-to-equity ratio of 5.74. Procaps Group has a 12 month low of $1.95 and a 12 month high of $4.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.